Latest Strategy News

Volt Resources has reshaped its executive team to sharpen focus on downstream graphite refining and advanced materials, appointing Trevor Matthews to its board while repositioning CEO Prashant Chintawar.

Tasmea Limited is set to acquire the Vertex Group, enhancing its high voltage and portable power services across regional Australia, with a deal expected to boost earnings per share by 3%.

HITIQ has secured a pivotal one-year deal with the South Metro Junior Football League, positioning its PROTEQT concussion management system at the heart of junior sports safety. This move complements existing partnerships and signals a strong push into Australia’s grassroots sports market.

Hydralyte USA reports its best EBITDA performance since IPO, driven by strong sales and cost reductions, setting the stage for growth with upcoming product launches.

Way2VAT Ltd has successfully raised A$2 million through a discounted share placement, aiming to bolster working capital and reduce short-term debt as it capitalises on recent client wins.

G11 Resources has appointed Martin Donohue as Executive Chairman to fast-track exploration at its Wilandra VMS Copper project while its CEO steps down, signaling a strategic pivot.

National Australia Bank has updated key details on its 2025 interim dividend, including dividend reinvestment and bonus security plans, setting clear terms for shareholders ahead of the July payment.

Golden Horse Minerals has successfully raised A$15 million to accelerate exploration at its Southern Cross Gold Project, with plans to expand drilling activities and pursue a potential copper acquisition.

Neurotech International has reported positive human pharmacokinetic results for NTI164, a cannabinoid formulation designed for paediatric neurological disorders, confirming rapid absorption and a non-intoxicating profile.

Green Critical Minerals has raised A$7 million through an institutional placement to accelerate the commercial rollout of its Very High Density graphite technology, aiming for first revenue in early 2026.

Lumos Diagnostics has reached 50% recruitment of bacterial positive patients in its pivotal FebriDx CLIA waiver clinical study, setting the stage for a planned FDA submission in late 2025 and unlocking a substantial US market opportunity.

Kingsgate Consolidated reports significant gold and silver intersections at its Chatree South-East Complex and Chang Puek Prospect in Thailand, nearing completion of its 2025 drilling program to support an inaugural resource estimate. Meanwhile, geochemical sampling at its Chilean Nueva Esperanza Project wraps up with results expected soon.